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INTRODUCTIOB
The first reference to digitalis was in the
treatise of the welsh physicians, A.

n.

1250 (24).

The first botanioal description of the plant and its
botanical name were furnished by

~uohsius

in 1542 (130).

Digitalis was later mentioned as an emetic and expectorant b1 Gerrarde in 1597 and Parkinson in 1640.
William salmon in 1707 recommended it for "Obdtruction of the liver and spleen," as an ingredient of
ointments for wounds and scrofula. and as beneficial
in epilepsy (107).

Its specific action was not observed

until Withering began using it in 1776.

!he story of

his discovery of this needs no retelling.
book was published in 1785.

:re.is famous

The accuracy of his obser-

vations and the soundness of his therapeutic use of
digitalis excite wonder when the incomplete knowledge
of physiology and pathology of his time is considered.
While he considered the drug as a diuretic. he recognized that it would not produce diuresis, in "encysted
dropsies" (ovarian cysts) or in ascites associated
with"visceral disease" (portal obstructionf.
slowing of the pulse after digitalis is

~dministered,

but oould not connect this with the diuresis.
·'

He noted

Withering•&

method of using the drug is classical, and, after frequently disregarding his rules for administra.tion with
unsatisfactory and often tragic results, the best

2

,....!

clinicians today use digitalis exactly as Withering
used it.

The only

di~ference

between the use of

digitalis today and its use by Withering are due to
means for

st~dying

the response of the patient which

were not available to Withering.
Cullen, in 1789, attempted to associate the
diuretic action of digitalis with "a general action on
the system" which also involved the slowing of the
pulse (24) •

.l!'erriar in 1799 spoke of its "sedative

power" on the heart and its "proper action in retarding
the velocity of the circulation."
In the first two decades of the nineteenth century
digitalis was heralded as a specific for phthisis, by
Beddoes and others.

Beddoea noted that in some patients

under digitalis the pulse rate was practically doubled
when the patient sat up in bed.

Currie and Bree found

patients in whom the pulse rate was not slowed by
digitalis.

Magennis found that digitalis, in some

oases, caused intermissions of the pulse at every third,
fifth or seventh beet, and often the pulse became
quite regular at :forty.

Vulpi:emn. in 1855 first used

animal e:x:perimenta.tion in an attempt dlo analyze the
action of digitalis (24).
The high points in the literature on digitalis
are marked by Withering•s great report of 1785, Fothergill's essay in 1871, and the more recent publications

•.:··

1.··'·

!'::J·

of Cushny, Christian and Luten.

The writings of

these five men have been freely used in the preparation of this paper.
The oardiac action of digitalis is not peculiar
to this plant, but Jligitalis purpurea is the best
Jtnown of a large group of plants, the active principles
of which vary only in potency and are known collectively
as "the cardiac glucosides." All but digitalis and
strophenthus have practically disappeared from use,
and• for convenience, this paper shall' consider these
only.
It is not represented that the bibliography includes all the great mass of literature which has
appeared on this subject.

An attempt

ha~

been made,

rather• to omit reports of all work which. however
worthy. does not bear directly on the ability of
digitalis to aid the patient with a damaged heart.

-
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OH.APTER I

EVIDENCE OF CENTRAL

ACTIO~

Sinoe Traube in 1851 discovered that the
slowing of the heart caused b7 digitalis could be
removed by section of the vagi, authorities have
differed widely over the question:
stimulate the

v~l

"Does digitalis

center cf the brain, and if it

does, of what importance is

thi~

therapeutic use of the drug?"

action in the

Fothergill in 1871

denied the theory of Traube (33).

Haynes in 1906

(54) found little decrease in the heart rate in the
atropinized heart perfused with digitalis and
expressed a belief that stimulation of the vagal
nerve endings is a large factor in the slowing of
the heart in the climical use of digitalis.
Maokenzie, who considered the therapeutic effect of
the drug to be due largely to its effect in slowing
the heart rate, thought that digitalis might act b7
stimulating the vagus nerve (74).

In 1913, Robinson

and Wilson studied the effect of digitalis on cats,
with and without the vagi cut (102).

With the vagi

intact, they found that an inversion of the Tmwave of

tr

the electrocardiogram occurred when 25% of minimum
lethal dose had been administered, prolongation of

5

conduction time at

5~

of them. 1. d., idioventrioular

complexes began to appear with 70% of the m. 1. d., and.
A•

v.

dissociation appeared with 80% of the m. 1. d.

\fhen the vagi were out, the inversion of the T wave
was found after administration of 25% of them. 1. d.,
but AT

v.

conduction and the heart rate were almost

unaffected by the total m. 1. d.
Two years later

3reene and Peller (46) reported ·

an experiment in which a turtle brain-heart preparation
was used, the heart being connected to the brain only
bJ the fibers of the vagi.

The brain was perfused

with fluid containing digitalis bodies.

The oardi••

inhibitory center was stimulated, as shown by heart
rate, and finally paralyzed, as shown by escape of the
heart.

Various degrees of inhibition were observed

during subsequent perfusion with Ringer's solution.
These authors report "not only is the rhythm inhibited.
but there is a blocking of the passage of the oontraotion wave from the vein and sinus to the ventricle by
a decrease in conductivity."
Further evidence of vagal stimulation is taken
from the blood picture.

An eosinophilia frequently

accompanies vagotonia (108).

Smith and Benner {116)

report that eosinophilia following digitalization was
l

reduced by adrenaline and atropine, but not by pilooarpine.

Romanll and Geiger (104) report a oaae of

6

eosinophilia in a digitalized patient in whom there

f"""':

was a fall in the eosinophile oount when digitalis

was stopped. and a oorresponding rise when digitalis

was resumed.
It seems, then, that digitalis has a vagotonic

effeot.

The 'imports.nee of this aotion in the thera-

peutic use of the drug has been questioned by leading
authorities, and will be considered again after the
action of digitalis on oardiao muscle has been discussed.

I

•
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CHAPTER II
EFFECT "!ON CONDUCTIVITY

It has long been known thet digitalis produces
aharaoteristio effects on the rhythm of the heart.
CushilJ< (.24) summarizes the effect of the glucosides
on the frog's heart as follows:

when the heart is

perfused with a. minimum quantity of digitalis, there
is first a period of delay, then the ventricle begins
to beat at one-half its original rate.

With continued

perfusion the ventricular rate is halved again, to
one-fourth original rate, the auricle's rhythm still
being unchanged.

This process may be repeated so that

the ventricular rate is one-eighth that of the auricles,
and finally the ventricle stops in complete diastole.
This change in rhythm is independent of the extrinsic
nerves, for it is not affected by atropine or curare.
Cusl!J.itJ7,~

,ore di ts Straub with being first to point

that this slowing results from the :failure of efficient
stimuli to reach or aot upon the ventricle.

Similarly,

he points out, the sinus may continue its rhythm while
the auricle beats at one-half rhythm.

There is also

diminished conduutivity within the ventricle.

This may

be exhibited by contraction of a part of the ventricle,
or by lowering of the T wave.

The halving of the

rhythm is often preceded by alternation of large and
small beats, the latter apparently being co,ntractions
of the base of the ventriole only.

•

There are two theories (24, .·66, 69. 71, 127) by

B

means of which the explanation of this block-producing
aotion has been attempted.

These are (1) that the im-

pulse fails to reach the ventricle, or (2) that, reaching the ventricle, it finds the ventricular muscle
unresponsive.

Evidence of reduced exeiteability under

digitalis is a reduction in efficiency of electrical
stimuli after digitalis administration, as found by
numerous investigators

(cuSbi.~~)&4).Clinicians

commonly

assume that the block-producing action of digitalis is
due to impaired A-V conductivity, a view which ia not
totally accepted by physiologists.

Erlanger (290) be-

lieves that both lowered A-V conductivity and lowered
ventricular exciteability must be considered important
faotors.

In summary, nthe question remains unsettled,

but the balance of evidence supports ousq1ut s contention
that digitalis acts at least partly on the oonduoting
tissues ( 12)."

•
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CHAPTER III
ACTION QN

VENTRICUL.~R

!IDSCLE

The characteristic action of digitalis on cardiac
muscle wss first observed by Vulpian on the frog heart
in 1855 (24), and was confirmed by several workers,

including Fagge and Stevenson in 1865, e.nd Fothergill.
This same aotion was found to result from strophanthus
by

Fraser in 1873, when he studied this drug as an arrow

poison used by natives of Afrioa.

The action is so

oharaoteristic that it has since been used as e test for
the presence of the cardiac gluooaides.

When a frog's

heart is perfused with sufficient glucoside, it stops
with the ventricle white and hard in a state of contraature, the auricles dark

~nd

distended with

dammed-back blood (30, 34).
In 1887 Folleston reported that strophanthin causes

e. marked rise in intra.ventricular pressure (103 l.
C~;

reported in 1897 that the shortening of the

ventricular fibers in
talis (24).
by

~~stole

was increased by digi-

An important observation was made in 1926

Harrison and Leonard (51).

These men found that

digitalis definitely diminishes the output of the
normal dog's heart.

The following year Burwell and·

hie associates (10) were able to report the same
results in normal. men.· In 1929 weiss and Blumgart (124),

10

working with vital oapaoity and arterial and venous
pressure measurements, found the following results:
(1) therapeutic doses of digitalis caused no
appreciable change in the cardiac output of normal
persons, and (2) of fourteen c&rdiao patients, seven
showed increased heart output, four showed no change,
and three showed decreased output.

Bodo previously

had stated that digitalis produces & tonic effect on
the heart. enabling the heart to expel the same amount
of blood with a smaller average heart volUJ1e (6).

Thie

may explain caees of heart failure in which clinical
improvement without increased heart output was observed
after digitalis administration.

Weiss and Ellis report-

ed four such patients. in 1930 (126}. and Friedman reported, of a group of twenty-two patients, eighteen who
showed clinical improvement with no consistent alterations of cardiao output in proportion to oxygen
consumption {35).
Cohn and Steelesumme.rize the effect of digitalis
on the output of both dogs and men as follows (22):
"l.

~igitalis

decreases the volume output of the

normal heart and decreases its size.
"2• The volume output of a failing heart is diminished and its size larger than when it ie in a state
of compensation.
"3. Digitalis increases the volume output of failing hearts and decreases their size."

11

"4. Digitalis. we think, has similar • perhaps
identical, actions both in normal and in diseased
hearts;

it decreases cardiac size and increases the

extent of ventricular contraction.

!he consequence

of these actions is that the volume of the cardiac
output which resulte,differs, depending on an initial
difference in size of the ventricular cavities, in the
two situations.

In the one, the normal heart, it be-

comes too small;

in the other, the diseased heart, it

develops a suitable size."
!he diuretic action of digitalis will here be discussed as a musuular effect.

That diuresis is secondary

to improved cardiac aotion was recognized by ·Fothergill
(13) in his essay in 1871.

xackenzie later cast doubt

on this theory because of his fallacy of taking slowing
of the heart rate as an index of the aotion of digitalis.
He found eases which, under digitalis, showed diuresis
before any slowing of the rate occurred, and other.
oases with heart block in which digitalis produoed
diuresis.

Because he was unable to understand any

oardiso aotion (74) of digitalis which did not resuli
from slowing, Mackenzie attributed diuresis to an extraaardiac action of digitalis.whXe1lldildinol911s1fib"8nclrcbll&t
'lltil'f~igi talis

when given to the healthy human subject

in therapeutic doses seems to exert slight. if an7
diuretic effect."

Eggleston states ( 28) that digitalis

12

produces no diuresis in patients vri thout congestive
heart failure.

Levy and Mackie (66) believed that

diuresis was due to improved renal circulation rather
than to direct action on the re11a.l epithelium, an
opinion which coincides with that of Herrmann. stone,
Schwab, and Bondurant.

Cushing is of the opinion that

"the removal of dropsy may causes diuresis, not vioa
versa • n

(

54a ) •

The question of whether or not cardiac hypertrophy
constitutes a valid indication for digitalis has been
discussed for many years.

Eminent clinicians have held

that a heart undereoing hypertrophy was responding
ne.turally to changed demands upon it and did not re quire
the stimulus of digitalis so long as symptoms of congestive heart failure were absent.

Fothergill, quoted

Niemeyer (33) "Digitalis in pure. uncomplicated hypertrophy
is unsuitable •••• Its use i.s indicated in diseases in
which the action of the heart is weakened, but never in
oases where it is augmented."

Fothergill agreed with

this, but recognized that hypertrophy was not a contraindication.
this belief:

Later cardiologists have largely held to
that hypertrophy is a desirable process in

a diseased heart, that as long as the heart can compensate for its deficienciee by increasing in mass, there is

l

no need for medication.

But now a new school has arisen,
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a group of men who believe that hypertrophy of the
heart is a bad thing !!.!!. !!_ (18), the beginning of
a process which leads to dilatation and congestive
heart failure, and that it should be avoided if possible.

It has been

suf~ested

also that hypertroph7

places a new obstacle in the path of a crippled heart
by making more difficult the supply of blood to the
heart wall.

Cloetta (18) showed that the hearts of

animals with experimental aortic insufficiency will
undergo great hypertrophy, but that this hypertrophy may
be largely prevented if digitalis is administered from
the onset of the lesion.

Thie immediately dispelled

early beliefs that digitalisia a cause of hypertrophy,
but thetl&las

lfJJtu.itsoplfr~.;

tlaeye-,ett..11ent

significant.

The hearts treated with digitalis were

~re

even more

found to be a!moat equal to normal hearts in absolute
reserve energy, while the hypertrophied hearts which
had not been treated with digitalis were quickly
exhausted.

sohwab and Herrmann (109) repeated Cloetta•e

experiment with a larger series of animals and also found
that digitalis has a restraining effect on cardiac
hypertrophy.

Cloatta considers every heart with dilata-

tion and hypertrophy as having diminished efficiency.

r
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CHAPTER IV
BIOCHEMICAL ACTION ON HEART MUSC:GE
The following is a, schematic representation of
the constituents of digitalis leaves (18):
Folia
potassium salts
Digitoxin
/
\
Digitoxigenin
(!giykon)

Bigitalin Gitalin
( Gitoxin J
Digitoxose

The active principles of folia digitalis are the
glucosides 1 of which the three mentioned above, digitoxin, bigitalin and gitalin, are the best known.
Each of the glucoeides contains a sugar component.
digitoxose, the inert porttion, and· a genin {aglykon),
the active portion.

Digitoxose is a common component

of all the glucosides, which vary in potency according to their genin fraction.

The genins alone are

less cardio-active than the total glucosides.
After digitalis is administered to an animal or
human subject, there is a latent period before its
effects become noticeable.

This latent period

(14, 17, 18, 86) is shorter under intravenous administration than when the drug is given orally, but even
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then is longer than could be required for simple
diffusion through the circulating blood.
The gluoosides hi1ve been shown to be orystalloids
with the property of passing through membranes by dialysis.

It has been shown (24) that the action of

digitalis is reversible only in the very early stage.

A short period exists during which the early action of
the glucosides may be stopped by perfusion of a heart
with Ringer's solution.

This is called the membrane

stage, and is believed by cloetta to represent the
period during which the glucoside passes through the
cell membrane.

After a few minutes, the action of the

glucoaides cannot be ·reversed by perfusion with
Ringer's solution (18), and al..l efforts to recover them
from the cells are fruitless.

Fluid containing a fixed

amount of a gluooside will affect each of a series of
hearts less rapidly than the preceding heart, indicating
that part of the active principle is taken out of the
fluid by each successive heart (Straub'a serial experiment).

(24).

It is believed that the glucoside ha.a

entered into combination with the heurt muscle {has
become "fixed") and that this fixation is chemical in
nature.
of

If this is a chemical union, the cumulative action

~igit~lis

might be easily explained.

After the

crystalloicPJmbl'eou1·e:: has passed through the cell mem-

brane and entered into chemical combination with the
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intracellular material, it will lose its identity as a
crystalloid and no longer exert osmotic pressure.
Another molecule will then pass through the membrane

and the process will be repeated.

Aa evidence that this

process is a chemical combination. Fischer (quoted by
Cloetta) has shown that all of the cardiac effects of
digitalis obeyed Vant Hoff's law:

the effect is

heightened in proportion to increase in temperature.
After fixation, the glucoeides are slowly broken
down into digitoxose and their genins (18).

The genin

is active and capable of continuing the digitalis
action, but is less firmly fixed in the cell, so that
they are gradually removed and their action ultimately
disappears.
The process of fixation ocours in other tissues
of the body, but is greater in heart muscle.

If the

amount of glucoside fi%ed in a given.mass of heart
muscle is taken as a unit, the a.mount fixed in other
tissues will be as follows ( 14) ·:
Heart Muscle

Skeletal Muscle Liver

Kidney

Digitoxin

l

1/14

-1/4

1/2

Ouabain

1

1/10

1/6

1/2

While heart muscle fixes four and fourteen times
as much digitoxin, weight for weight, as the liver and
skeletal muscle, respectively, because of the difference
I

in mass of these organs. the liver fixes approximately
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the same a:nount of digitoxin as the heart, and skeletal
muscle fixes more.

For the same reason a hypertrophied

heart absorbs a larger proportion of an equal sized dose
of digitoxin than a heart of normal size, and thus recaives more benefit from a given dose of digitalis than
does a non-hypertrophied heart •. Other factors affecting fixation are the rate of flow of the blood through
I

the heart and the time the digitoxin is in the circulation. which is longer for glucosides administered
orally and shorter for those administered intravenously.
The exact manner in which digitalis aots on heart
muscle is not known, but curious aimilarities between
its action and that of calcium have been found.

Clark

in 1919 stated that the increased force of contraction caused
by digitalis was opposed by the presence of acid. or the
absence of ca.lei um from the per fusing fluid (16).

Loewi

(quoted, 24) thought that strophanthin did not act iri
Ringer's fluid which was free of calcium.

Pietrowski

(24) 1 however, corrected the change in osmotic pressure by
substituting sugar for calcium in the Ringer's solution
and found that the strophanthin acted as normally.
Ransom in 1920 arrested the movements of excised cat•s
uterus by placing

~t

in

~inger's

fluid containing no

calcium. and found the movements restored and usually
increased by the addition _of strophanthus ( 92).
{

Re also·

found that a short exposure of uterine muscle to s .::' :;-
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strophanthus made it extraordinarily responsive to
calcium.

Bower and Mengle (6)1n 19Z6 found that pre-

viously digitalized dogs showed toxic effects from
calcium in doses which were much smaller than were
without digitalis.
required when given~ They also reported two oases of
sudden death from intravenous caloium administration
of patients to whomdigalen had been administered
previously without toxic effect.
Oloetta in 1929 stated that calcium and digitalis
have different points of attact and that their actions
cannot be identical (18).

In 1916 Peters and Visscher

(89) reported, "Calcium increases the oxygen consumption
and efficiency of the heart muscle at constant external
diastolic volume.

Glucosides of the digitalis aeries

have the same action as calcium, but the maximum effect
is delayed."
Recently oatte 11 and Goodell ( 11) reported that
the digi tali& gluoosidea cause the frqr sart.orius muscle
cell to lose potassium.

Simultaneously with this, Bahum

and Roff announced electrooardiographic evidence (81)
that the actions of calcium and

dtg~tajiis

of normal rabbits are not additive.

on the hearts

At the present

time the exact mechanism of the cardiac action is not
known, but

evidenc~

seems to point to some connection

with the calcium - potassium ratio in the heart muscle
cell.
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CHAPTER V
EFFECT ON CORONARY CIR'JULATIOJf
The possibility of inducing attacks of angina
pectoris in certain patients by the use of digitalis
has justifiably stimulated a certain amount of study.
Gilbert and ?§ml reported a tendency for attacks of
anginal pain (31) to be more frequent under digitalis
and subsequently cited evidence which appeared to
show that digitalis might have a vasoconstrictor action
on the coronary vessels of dogs ( S6).

Bodo· ( 5) • using

small amounts, obtained an increase in flow through
the coronary vessels.

~old

(~7)

found that "a heart

that has been in ventricular fibrillation from coronary
occlusion and has recovered temporarily also shows no
diminished tolerance to the toxic action of d.igi talis."
He found that varying degrees of coronary obstruction
did not"alter the average fatal dose of digitalis for
seventeen animals.

Gold an1 his associates have recently

reported a series of 120 patients with arteriosclerotic
heart disease who were given digitalis alternated with a
placebo.

As a result of th•tr)>bservationa. they reported,

"Digitalis in large doses rarely. if ever produces
effective constriction of the coronary arteries in man."
( 43).

'

.

These conclusions confirm tlke observations made by
Fothergill over half a century pgeviously.

~othergill

pointed out that the coronary vessels are filled
"arterial ep.stole":

by

the

by the pressure of blood in the

·aorta during cardiac diastole, and that digitalis, by
its action on the cardiac muscle, increases the filling
of the aorta

by

ventricular oontraotions 9 and thus in-

creases coronary circulation (33).

Regardless of what

experimental evidence points to coronary constriction
by digitalis, this powerful and opposing action must
not be lost eight of.
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CHAPTER VI
T~

THERAPEUTIC ACTION OF DIGITALIS

With a drug that affects the heart by several diff. erent methods at the same time, that produoee varying
effeots with varying dosages, and that seems to aot
differently on normal hearts than upon abnormal
hearts, it is not difficult to understand that a degree
of confusion has long existed so far as the therapeutic
action of digitalis is concerned.

For this reason a

discussion of the therapeutic use of the drug has been
largel1 deferred until its several actions on the heart
have been examined.

It is now proposed to consider

of those actions in the light of its importance in the
treatment of the failing heart.
It has been rather well established that digitalis
is a vague stimulant and is capable of slowing the heart
by

its vagal action.

rt has also been established that

digitalis slows the.heart in certain cases of heart
failure.

The natural but unfortunate assumption that

the beneficial effect of digitalis is the result of
vagal slowing has confused.the picture and resulted in
a great deal of improper use of the.drug.

Mackenzie

thought that heart failure was benefited b1 digitalis by
a primary slowing effect which he thought might be due to

2f

vague action.

But Mackenzie thought of the effect

of digitalis only in changes of heart rate.

He

could not explain cases in which clinical improvement
followed digitalis administration before slowing
occurred, nor could he explain the improvement of
patients with normal rhythm in whom no slowing was
obtained.

The appearance of diuresis before slowing

in patients with congestive heart failure was believed
by him to indicate that diuresis was an extracardiac
effeot of the drug.
Parkinson in 1917 found that digitalis produced
no slowing in soldiers with "i.rri table hee,rt" and a
fast pulse {87).

Since then ample evidence has accumu-

lated that digitalis produces little or no slowing in
normal rhythm cases or in the normal heart, in therapeutic doses.

rt has been shown that digitalis produces

clinical improvement in congestive heart failure cases
without tachycardia as well as those with tachycardia.
LUiftY; believes that tachycardia in heart failure is a
reflex phenomenon, a physiological adjustment which is
compensatory to impatirmfJnt

of cardiac}>utput (71, 128).

He concludes that the abatement of tachycardia is not
the ca.use of the improvement, but the result of it,

,

and that the direct sinus slowing of the heart is of
little/ or~'-1'.lO significance so far as beneficial results
.,...,..,..'··

are concerned.

The most recent authoritative opinion

is. then, that slowing of the heart under the there.•

23

peutio

use of digitalis is due to "action on the

muscle - an action whereby the. heightened irritability
of the muscle is reduced (71)."
Action 01.f the A-V tissues an an important therapeutic eff•ot of digitalis oannst be dismhesed so
easily.

Thia theory bas been.firmli>•stabiished in the

minds of cardiologists largely through the writings of
Mackenzie and Lewis (67• 73, 75).

These men considered

auricular fibrillation to be the prime indication for
digitalis therapy, and slowing of the heart rate to be
its only beneficial result.

There is an abundance of

experimental evidence to show that digitalis does have
an inhibitory effect on the conduction tissues of the
heart.

When Broadbent (7) in 1917, dared to state that

increased strength of contraction and not depression of
conduction produced the beneficial results of digitalis
treatment, he was immediately the target of bitter
attack by Lewis (68).

Broadbent

poin~ed

to oases of

heart failure without auricular fibrillation in which
clinical improvement was obtained by digitalis, and to
eases of auricular fibrillation not due to heart failure
in which no change in rhythm was obtained by digitalis.
Lewis challenged Broadbent to produce a series of cases
to support his belief.
~·

During the next twenty years

these oases ( 13, 71. 88, 119) have been furnished in
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abundance, and, moreover, Mackenzie's own cases have
been critically analyzed to show the error of their
conclusions.

That depression of A-V conduction

plays a part in restoring normal rhythm to some cases
of auricular fibrillation with heart failure cannot be
denied.

Luten's recent book contains an analysis of

Mackenzie's cases.

It is shown that in-oases where

great clinical improvement was noted, but without
change in rate, Mackenzie said "Digitalis had no effect
on the heart." (74).

While he agrees that digitalis

does have an effect on A-V conduction which in some
oases is sufficient to slow the heart, especially in
auricular fibrillation or am:'icular flutter, Luten (71)
aonoludes that the "special effect on the A-V tissues •••
has been assigned a prominence altogether out of proportion to :t.:ta importance when compared to the indication for

obtai~ing

muscular effect."
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CHAPTER VII
INDICATIONS AND CONTRAINDICATIONS

It has been established in preceding paragraphs
that the major therapeutic effect of the digitalis
glucosides results from their aetion in increasing the
contraction of cardiac muscle.

This section will be

based on that premise and its logical conclusion:

that

the prime indication for the use of digitalis is myocardial insufficiency.

Following Mackenzie's noteworthy

observation that digitalis slows the heart rate only in
auricular fibrillation, and the subsequent emphasis of
this observation by Lewis there was a period of some
twenty years during which auricular fibrillation was
considered the principal indication for digitalis.
Almost at the same time that Lewis was teaching this,
however, Wenkebach was ss.ying that "digitalis is indicated in all cases of heart failure ••• irrespective of
the cause of the heart failure its elf. n

(

123}.

Since

then a large number of men, mostly Americans, have
compiled series after aeries of cases to show that
digitalis will benefit auricular fibrillation only when
the fibrillation is due to heart failure, and that it
will produce clinical improvement regularly in oases of
heart failure without auricular fibrillation (1, 24, 50,
71. 76a. 119).

In other words, the leading clinicians
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have returned to the principles of Vithering and
Fothergill.
so firmly established is the spefifio action of
digitalis in congestive heart failure that clinicians
are almost willing to define congc.stive heart failure
as a disease which is benefited by digitalis.

Thia

has led to two new and interesting uses for the drug:
its use in potential heart

f~ilure

and its use as a

diagnostic procedure in certain puzzling cases in which
early heart failure is suspected.

uigitalis has

commonly been used to prevent the repetition of
attacks of heart failure (39).

This application has

now been extended to include the use of digitalis in
preventing or postponing initial attacks of heart
failure in patients with known or suspected heart
damage.

This use of digitalis has been advocated

chiefly by Christian (15).

aaa

He finds this "tonic"

especially effective in older patients with hyper-

trophy or other evidence of arteriosclerotic heart
disease.

This use of digitalis is strongly supported

by the experimental proof, presented by Cloetta (18, 109),
that digitalis definitely prevents cardiac hypertrophy
after experimental valve lesions, and conserves cardiac
reserve.

Christian points out that the effects of

digitalis in these cases of "occult" or "potential"

·r

heart failure. while less dramatic than its effect in
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arresting auricular fibrillation, are a beautiful
demonstration of the great flexibility of digitalis
dosage.

rt has been shown elsewhere in this paper

tbflt a hypertrophied heart absorbs more of a given dose
than a normal heart,
of digitalis, and that when the rate of blood flow
through the heart is slow, the heart absorbs more digitalis
than when the rate of flow is fast.

In the tonic use

of digitalis, as the heart begins to undergo hypertrophy
and the circulation becomes sluggish, more digitalis is
absorbed by the heart.

In other words, when the heart

needs more digitalis, it absorbs more;
less, it absorbs less;

when it needs

and the physician need not

change his dosage in either case (15).

Luten (71)

warns that the tonic use of digitalis should not be
attempted in young patients who may still harbor active
infection.
The use of digitalis in diagnosis and prognosis is
less

com.~on.

Luten points out that auricular fibrilla-

tion may be an early sign of congestive heart failure in
older patients, and that abatement of this by digitalis
would be of diagnostic va.lue.

He states also that this

may be done in certain oases presenting such SJDBptoms as
enlargement of the liver, in which the diagnosis is not
quite clear.

Goldring and Grunbaum state that the

degree of response to digitalis is an indication of the
f

·extent of myocardial damage and the amount of cardiac
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reserve, and as euch is of prognostic value.
The etiological classification of heart disease
has often been considered in relation to the use of
digitalis.

Corrigan in 1832 announced that aortic

insufficiency contraindicated digitalis, a belief
that persisted for many years (23).

corrigan•s statement

was based on the supposition that digitalis increased
aortic regurgitation by lengthening ventricular diastole,
and upon one case which showed increased symptoms after
the treatment was dtaed>nt.tllued and the patient "allowed
to live a normal life."

Investigation shows the treat-

ment included frequent cupping, bleeding, and starvation
among its several

benefits.

rt is difficult to judge

how much of the patient's improvement resulted from the
discontinuance of digitalis and how much from being
"allowed to live a normal life."

Balfour (2} in l89r

denied this lesion as a contraindication, stating that
digitalis diminished the area of the base of the arterial
col~

bJ contracting the heart.

rt is recognized that

digitalis is of leas benefit in aortic insufficiency
than in other valvular lesions.
on the severity of the lesion.

This probably depends
But many cases respond rath

er favorably, and certainly a greater need for digitalis
is not a contra-indication to it.
L

Marvin (76a) found

that digitalis resulted inronsistent improvement only
in arterio-selerotic heart disease, and almost devoid of

29

effect in rheumatic heart disease.

J

This does not

coincide with the general clinical opinion, and
Marvin explains that his failure to obtain good
results in cases of rheumatic heart disease

by

say-

ing that the "signs and symptoms of heart failure
represent a later stage of failure in the rheumatic
group." ( 76a).
The effect of digitalis on the coronary artefies
has been discussed.

It has been explained that digitalis

in therapeutic doses does not increase the frequency of
anginal pains in failing hearts, but may reduce them.
This, then, does not constitute a valid contraindication
for digitalis, providing heart failure is present.

In

anginal pain without heart failure, the work of Stewart
and Cohn in showing that an increase of pain may result
from the established effect of digitalis in decreasing
the output of the normal heart must be considered {118a).
As it stands now? angina pectoris without heart failure
is not an indication for digitalis.

The same reasoning

holds for the use of digitalis in coronary occlusion,
except that recent work suggests that there may be a
.
diminished tolerance to:· digitalis after coronary occluaion (71).

For this reason, digitalis should be used

cautiously in cases of coronary occlusion (37).
The use of digitalis in thyrotoxicosis has fallen
into disrepute.

~he-

toxemia in this disease seems to
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alter the toxic threshhold of the heart (32).

Experi-

ence seems to indicate that auricular fibrillation

in

toxic thyroid disease is better controlled by removing
the oause, while heart failure is an indication for
digitalis (93, 80, 106).
In shook digitalts is of no value, either in
or treatment,
prevention
Shook is probably a result of peripheral
circulatory failure rather than cardiac failure, and no
results would be expected from its use.

It is therefore

not indicated. (71, 121).
The use of digitalis routinely in pneumonia has
been studied oarefully.

While there is some slight

evidence that routine digitalis administration in pneumonia might be of value f 64}, the general principle
that digitalis is of little value in acute febrile
states (121) which probably involve peripheral circulatory failure has been supported by clinical evidence.

wYkoff

DuBois and woodruff reported, in 1930, a series of oases
in which alternate patients only were given nigitalis.
They found the following comparative mortality:

NO Digitalis
Total

Died

404

136

Digitalis
Mortality
33.7%

Total

lied

Mortality

338

140

41.4%

They conclude that digitalis is dangerous in

t

lobar pneumonia ( 131).
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The use of digitalis in ~cuptitmmia;m a routine
is discouraged because the diptheria toxin ptoduces the
same tosic effects on the heart as does digitalis (179),
and only definite heart :failure cal"is for digitalis (71).
Active rheumatic fever is considered by some to be a
conttaimdteation for digitalis, and by others to call
for care in dosage.
The practice of giving digitalis in circulatory
failure due to toxemias, acute infections or other
acute febrile states without direct indication but as a
sort of "lust resort" therapy in cases which do not
yield to other therapy 18 generally condemned (122) •
.Attention is called to the effP.ct of temperature, in
increasing the effect of t.3mperature on the rapidity
of action on digitalis (48) and to the report by.
Robinson that (quoted, 71} toxic effects are secured with
lower dosages in febrile patients.

This should call for

exceptional wetcbfulness in the use of digits.lis where
patients with fever and true indications for digitalis
are concerned.
The use of digitalis in heart block depends on the
extent of the block.

In partial

~eart

block, the ques-

tion of an increase of the block by the action of
digitalis on the conduction system has been brought up.
This has caused partit:!.l heart block to be a. contraindication for digitalis.

This opinion has changed.

It is
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considered that the beneficial effect of digitalis
when indicated might outweigh any block producing
effect.

warning is given that digitalis may precipitate

Adams - Stokes atta.cks in the transl tion period he tween
partial and complete block.

This must be weighed

against the possibility of lessening the attacks by
improvement of heart action, or the elimination of
the attacks by converting of partial block to complete
block (28).

Complete heart block is no contraindication

fo" J.igitalis, for the block cannot be increased (110)
(94)

Bundle branch block has sometimes been regarded

as a oontraindioation to digita.J.is, but clinical results
have disproved this (52).

The use of digitalis in oases
toles is not well understood.

~ing

extra sys-

The fact that digitalis

may produce extra systoles is •ell known (55, 71, 114, 90).
On the other hand, cases of extra systoles abolished by
digitalis are frequent.

The same is true for paroxysmel

tachycardia, auricular ::·:1iibrillation and alternation.
!J'.'hese all may result as toxic effects of d.igi talis, but
when due to heart failure, may be abolished by digitalis.
It follows that the appearance of one of these arrhythmias during the administration of digitalis should require
the stopping of the drug, but that otherwise they are not
contraindications (3, 4, 26, 112. 95, 96).
The use of.digitalis with ephedrine (60), calcium
or barium is lo be accompanied with caution beoause of
the possible additive effect of the drugs in producing
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toxic symptoms.
Experimental evidence that digitalis oauees con•
striation of the arterioles (9, 24, 25) has brought up
the question of its use in hypertensive patients.
There is little eviden·ce the.t digitalis in therapeutio
doses causes vasoconetriotion in man.

The commonest

finding is & transient and slight rise in systolic
pressure.

If increaeecl cardiac output induced by

digitalis in heart failure patients results in increased
arterial pressure, as it certainly must in some cases,
there must be an accompanying vasodilation or other
oompensator7 reflex adjustment.

HiPertension ia not

considered a contraindication to digitalis.
The routine

pre~erative

use of digitalis ie con-

demned as being not indicated (77).

If indication

exists, digitalis should be given pre-operatively in
effective doses.

/

r'
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CHAPTER VIII
TOXIC EFFECTS

Jaueea and vomiting as caused by digitalis have
been known almost as long as the drug itself, for one
of its aarlieat uses was as an emetic.

But Withering

was first to recognize them as toxic effects rather the.n
as therapeutic effects (130).

rt was originally be-

lieved that this was a result of gastric irritation,
later that it was due to the action of digitalis on
the vomiting center of the medulla.

Hatcher and

Weise (53) showed that vomiting could not be produced
in animals by perfusing the brain with the gluooaides,
but that it could be prevented by cutting the nervous
oonneotions of the heart.

Nausea and vomiting are,

therefore, the result of a reflex originating in the
heart.

1his was confirmed in man by Eggleston and

Wyckoff (29).

The importance of this is in showing the

!Utility of attempts to continue digitalis by rectal
administr\ltion aft.er the onset of vomiting due to
digitalis.
aaorexis.

usually there is a prodromal period of
The vomiting reflex is a protective mechan-

ism which mayi in some cases of overdosa.ge, remove the
unabsorbed excess of digitalis from the gastro-intestinal
tract.

This is of theoretical interest only9 for only

time can remove the to:xic dose which is fixed in the
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heart muscle.

The nausea and vomiting may appear in

successive attacks. often over a period of several
days, alternating with periods Of freedom (130).

Gold,

Travell, and XWit have observed that, after an initial
period of vomiting, there may be a depression of the
vomiting center so that death may ensue without e
recurrence of vomiting.

This is clearly of clinical

importance ( 44) •
Cerebral s1..rnptoms are of importance and may be
the earliest toxic manifestations.

Headache is most

common. Bisturbancesle>f vision, particularly color
perception, are of importance (130 1 117).
~he

greatest variety of toxic effects is referred

to the heart.

A toxic degree of A-V conluction is a

well known symptom, even tu t!'l.e extent of complete
block.

~ince

a certain amount of A-V block probably

ocaurs in the therapeutic range of digitalis administration, the degree of impairment of conduction must be
evaluated in interpreting this action as a toxic effect.
The same may be said for extra-systoles and sinus
arrhythmia.

Auricular fibrillation (59), auricular and

ventricular tachycardia, A-V dissociation, and ventricular
fibrillation may be observed with higher degrees of toxicity.

A special type of ventricular tachycardia which

shows an alternate reversal in the direction of the
QR S complexes has been recorded many times. and usually
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p~ecedes

ventricular fibrillation and de8th (78, 84,

116, 82).

Withering in his early use of digitalis used the
appearance of toxic symptoms as an indication that the
therapeutic zone of action had been reached, but later
learned that by being aware of climical signs of improvement, he did not have to subject his patients to
the discomfort of toxic effects.

rn this he was far

ahead of many later users of the drug.
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CHAPTER LX
ADMINISTRATION AND DOSAGE
There are several sources from which the digitalis
gluoosidas are obtainable.

These sources vary consider-

ably in their absorbability, rapidity of action, rate of
elimination, and potency (49).

There is no.essential

difference between them, however, in the order of events
observed eleotrocardiographically after the ad.ministration
of suooessive fractions of lethal doses (42).

The re-

quirements of a satisfactory preparation are:

(1) It

must be of known potency.
able.

(2)

It m1ist be readily avail-

(3) It must be easily prepared.

(4)

It must be

in suoh a form that the dosage can be easily controlled.
Digitalis purpurea fulfills these requirements
batter than the other plants, for oral or rectal use.
Strophanthus has been shown to be more satisfactory for
intraveno~e

use.

There is a larger fund of data available

regarding the use of digitalis than the other plants of
the group.

The powdered whole leaf has been fo11nd superior

to other preparations since the time of Withering.

It

is cheap, O·f highly constant potency. and, when properly
prepared, its deterioration is negligible.

The tincture

deteriorates slightly, and the infusion much more so.
Furthermore, oorreot dosage is more difficult when the
fluid preparations are used;

me~surement

by drops is

completely unreliable and measurement by a graduate is
inconvenient.

!he proprietary products and purified or
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concentrated glucosides have no added virtue for
general use, and are more expensive (66).

Furthermore.

the control of dosage, instead of being aided, is made
more difficult by the pure substances, for as the potency
of the preparation is increased. the mass of the dose is
correspondingly bcreased and the.measurement and administration of fractional doses interfered with.

Further-

more, the claims of pharmaceutical houses that their
preparations will not cause nausea or other toxic symptoms are either admi·ssions of lack of potency or deliberate misstatements of fact, for toxic symphtoms

res~lt

from quantity, not quality.
The cardiac glucosides are
gical assay.

stand~.rdized

by biolo-

The oat method of Hatcher had been found

to be the most reliable•

The unit of potency under this

methodiis the Cat Unit:

the minimal lethal close for oats

per kilo of_ body weight.

For orystallin g-strophanthin

this is rather constantly 0.1 mg. per kilo.

Digitalis

leaves vary in potency, but the average is fairly
constant at one oat unit per deeigra.m Clt grains) and
the better preparations are adjusted to this strength
b;y blending.

Oral administration is the most commonly used and
most satisfaojory method (101).

In cases of nausea not

due to digitalis intoxication, rectal administration may
be employed, using diluted tincture, suppositories of
whole leaves, or a suspension of the lee.ves in water or
. -:·
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starch paste.

The rectal dose is the same as the

oral dose {63).

Rectal administration is usually pre-

ceded by a cleaning enema.

rn rare cases where a

genuine need for quick action is present, parenteral
administration

may be justified {101. 85, 49).

However, intravenous medication is dangerous and
seldom justified, for the interval between administration and effect is not markedly reduced {17}.
The full therapeutic effect of digitalis is not
observed for several (eight to

a large dose.

twenty~four}

hQJ!lrs after

The earliest effects are seen in two to

three huurs, and some effects may persist for periods
of two weeks or longer after full digitalization.

This

makes it obligatory for the physician to determine if a
patient has been given digitalis within the previous
three weeks before ordering a full therapeutic dose.

If a possibility exists that a patient may have had digitalis within this period, or if the accurate information
cannot be obtained, the physician must proceed very
cautiousl;y,.

Disastrous results have followed the giving

of full therapeutic doses to patients a.lready partially
dtgite.U~~ •
..:

The persistence ·of action, the cumulation of effect
of digitalis are such as to permit the most flexible and
intelligent use of the drn.g in proper hands.

\Vhile the

e:xaot mechanism )f excretion or destruction of digitalis
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is unknown. it has been established that the rate of
disappearance from the body is not a fixed amount, but a
quantity ·that varies Vlith the amount of digitalis present in the body (40, 83).

By taking advantage of the

cumulative action and flexible rate of excretion, a
cumulation of effect may be built up to a desired level
of therapeutic action by repeated fractional doses, then
the level maintained by a small daily dose {41).

By

reason of varying rate of disappearance, a patient may
be fully digitalized by the daily administration of a
small dose whioh may be continued as a maintainance dose.
The therapeutic effect may be maintained at any desired
level by adjustment of

dosag~.

The optimum therapeutic

level approaches the toxic zone of action more closely
in cases of mild heart damage, and is very close to the
toxlc zone in children.
The effective dose is the quantity of the drug
which becomes available to the heart in producing a
certain level of effect.

The average effective dose of

digitalis has been determined by

~ggleston

to be

o.

146

oat unit per pound of body weight (29), usually given
over a period of thirty-six hours.

On this basis, the

following formuli for estimating the probable effective
dose have been arrived at (Christian):

('·.

f
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(12a)

Single Dose Method
Av. total dose {oral)

o.15/lb. of body wt.

c. u. X 0.15 X W: gm. powdered leaf.
1000

u. U. X 0.15 X W- c.o. tincture.
100

-

=c.o. infusion.

c. u. x o.15 x w
10

Modified Large nose Method
1/4 total dose given and repeated in 4 hrs. Remainder
given in O.l or 0.2 gm. doses
hrs., or
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0.5
gm

-q 4 . hrs. to end of

gm

1st dose, 0.6 gm in 4 hrs., then 0.1 or 0.2

q 4 hrs. if patient is awake

un~ill

pulse gegins

to slow or diuresis or nausea appears.

small Divided Dose Method
0.2 gm. or 0.1 gm. t. 1. d. until s igne of digitalis
appear.

It must never be forgotten that "these represent
quantities which, in the average, should be regarded
rather as doses not to be exceeded than as doses to be
administered;
dosage."

as top dosage rather than as optimum

The effeoti ve dose va:fies from the a.verage

enough so that these are to be considered as guides

to

dosage rather than a.s fixed dosages to be administered
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by rule to all patients.

serious results have followed

the use of large doses based on the weight of edematous
patients.

There is no substitute for close clinical

observation during digitalis administration.· Digitalis
should be administered in safe doses and stopped for
several days if toxic SJUDptoms appear.
The maintenance dose is the amount

~hich

must be

supplied daily in order to maintain effect at the desired level.
The average maintenance dose is approximately one
cat unit (li gr. powdered leaf) for the adult (86).
Optimum maintenance does vary widely as does the therapeutic dose.

Therefore it. too, must be arrived at by

intelligent irials with the individual patient (8).
The use of digitalis in children varies somewhat
from its use in adults.

There is no qualitative differ-

ence between the action of the drug in children and in
dose of
more
adults, but children require a therapeutic about 50% than
adults when determined by the weight method, and the improvement seen in children is less striking than that
seen in adults.

sinus slowing occurs early in children,

but nausea and vomiting are late manifestations and cannot
be used as oriteria in estimating the optimum therapeutic
dose.

Digitalis is. of course. contraindicated in children

with acute or chronic rheumatic disease (58, 79, 111,

11~).
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The electrocardiogrWli has been found to be an
excellent quantative index of the amount of digitalis
effective in the body.

Since the time of Withering it

has been necessary to administer digitalis until visible
therapeutic or toxic effects were observed (33, 91, 130),
and these were oftan noted too late to avoid unpleasant
effects.

The electrooardiogram will disclose that the

therapeutic level of digitalization has been reached
before more obvious evidences appear.

The Character-

istic inversion of the T wa.ve, or any other less characteristic change in the electrocardiogram which appears after
digitalis hns been administered may be taken as a signal
that the therapeutic zone of action has been reached, and
the maintenance dosage begun (8, 19, 20, 61).

\

ti\
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